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The mechanisms by which APP and AI3 exert their pathogenic effects have not been fully elucidated (Matt son, 1997) . Recent evidence suggests that APP overex pression and AI3 accumulation impair the function of the cerebral circulation (Iadecola et ai., 1999; Zhang et aI., 1997) . Transgenic mice overexpressing mutant or wild type APP have a selective alteration in cerebrovascular reactivity to acetylcholine (ACh), bradykinin (BK), and the calcium ionophore A23187, agents that act by releas ing vasoactive factors from the endothelium (Iadecola et ai., 1999) . The deficit in endothelium-dependent vasodi lation is not observed in mice overexpressing both APP and the superoxide scavenging enzyme superoxide dis mutase-l (SOD; Iadecola et ai., 1999) . Furthermore, ap plication of exogenous SOD to the cerebral cortex re verses the attenuation in endothelium-dependent vasodi lation in APP transgenic mice (Iadecola et aI., 1999) . These findings suggest that APP overexpression results in profound alterations in cerebrovascular function and that the effect is mediated through production of reactive oxygen species.
However, it has not been established whether the ce rebrovascular alterations observed in these transgenic models result from APP itself or from peptides derived from APP processing. Amyloid precursor protein is cleaved by secretases to pro duce several peptides, in cluding A[31-40 and AI31-42, which are thought to me diate the pathogenic effects of APP overexpression (Sinha et aI., 1999; . Therefore, in the current study, the authors investigated the cerebrovascu lar effects of synthetic A[3 peptides on the cerebral mi crocirculation of mice. The authors found that superfu sion of the cerebral cortex of normal mice with A[31-40 attenuates resting cerebral blood flow (CBF) and reduces the increase in CBF produced by endothelium-dependent vasodilators. These effects are reversed by treatment with superoxide scavengers and are abolished by substi tution of the methionine residue in position 35 with nor leucine, a modification that prevents A[31-40 from gen erating free radicals (Varadarajan et aI., 1999) . The find ings provide evidence that A[31-40, through production of reactive oxygen species, mediates the cerebrovascular dysfunction induced by APP overexpression, and raise the possibility that this peptide is also responsible for the cerebrovascular alterations observed in patients with AD.
MATERIALS AND METHODS
Methods for surgical preparation of mice, for topical appli cation of drugs, for monitoring CBF using laser-Doppler flow metry, and for measuring cerebral glucose utilization (CGU) using quantitative autoradiography have been described in de tail in previous publications (Iadecola et aI., 1999; Niwa et a!., 2000a; Zhang et a!., 1997) and are summarized briefly below.
General surgical procedures
Studies were conducted in 75 C57BLl6J mice (aged 2 to 3 months, weighing 20 to 30 g) obtained from Jackson Labora tories (Bar Harbor, Maine, U.S.A.). Mice were anesthetized with halothane in 100% O2 (induction: 5%; maintenance: I % to 2%). Trachea was intubated and mice were artificially venti lated with an oxygen-nitrogen mixture. The O2 concentration in the mixture was adjusted to provide a Pao2 of 120 to 140 mm Hg (Table I) . One of the femoral arteries was cannulated for recording of mean arterial pressure (MAP) and collection of blood samples. Rectal temperature was maintained at 37°C using a thermostat-controlled rectal probe connected to a heat ing lamp. End-tidal COz, monitored by a COz analyzer (Cap star-lOO; CWE, Ardmore, PA, U.S.A.), was maintained at 2.6% to 2.7% (Niwa et aI., 2000a;  Table I ). After surgery, halothane was gradually discontinued and anesthesia was maintained with urethane (750 mglkg; IP) and chloralose (50 mg/kg; IP). The level of anesthesia was monitored throughout the experiment by testing corneal reflexes and motor responses to tail pinch. To minimize confounding effects of anesthesia on vascular reac tivity, the time interval between administration of urethane chloralose and testing of CBF responses was consistent among the groups of mice studied. 
Monitoring of cerebral blood flow
A small craniotomy (2 x 2 mm) was performed to expose the parietal cortex, the dura was removed, and the site was super fused with Ringer solution (37°C; pH: 7.3 to 7.4) (Niwa et a!., 2000a; Zhang et aI., 1997) . Cerebral blood flow was monitored continuously at the site of superfusion with a laser-Doppler probe (Vasamedic, St. Paul, MN, U.S.A.) positioned stereotax ically on the cor tical surface. Cerebral blood flow values were expressed as a percentage increase relative to the resting level. Zero values for CBF were obtained after the heart was stopped by an overdose of halothane at the end of the experiment. Although laser-Doppler fl owmetry is not quantitative, it moni tors relative changes in CBF quite accurately (Dirnagl et aI., 1989; Iadecola and Reis, 1990) .
Cerebral glucose utilization
Cerebral glucose utilization was determined using a modifi cation of the 14 C-2-deoxyglucose (2-DG) method (Meibach et aI., 1980; Niwa et aI., 2000a; Sokoloff et aI., 1977) . Mice were anesthetized and surgically prepared as described for the CBF experiments. One of the femoral arteries was cannulated and used for recording of MAP and collection of blood samples. '4 C-labeled 2-DG (New England Nuclear, Boston, MA, U.S.A.) (20 /-LCi/100 g in 1 mL 0.9% NaC I) was injected intraperitoneally, and approximately 60 /-LL arterial blood was collected I, 5, 7, 10, 15, 20, 25, 35 , and 45 minutes later. One blood sample was collected before injection of 2-DG. These sampling times were selected in preliminary experiments to accurately resolve the arterial concentration time-course of the tracer. Blood samples were centrifuged and stored on ice. Tech niques for determination of tissue 2-DG concentration by quan titative autoradiography have been described previously (Niwa et aI., 2000a) , but were only summarized. Brains were removed rapidly and frozen in isopentane cooled to -30°e. Serial sec tions (20 /-Lm) were cut through the brain using a cryostat (Hacker-Bright, model OTF, Fairfield, NJ, U.S.A.), mounted on glass slides, and apposed to x-ray film (Sterling Diagnostic Imaging, Newark, DE, U.S.A.) together with calibrated 14 C standards (Niwa et aI., 2000a) . Fourteen days later the film was developed and the optical density (OD) of regions of interest was determined bilaterally on four adjacent sections using a computerized image analyzer (MCID system; Imaging Re search). Optical density was transformed in 14 C concentration (nCi/g) using the standards on the film (Niwa et a!., 2000a) . Radioactivity (nCi/g) of plasma samples was determined by liquid scintillation counting (Niwa et aI., 2000a) . Plasma glu cose was measured using a glucose analyzer (Beckman) . Ce rebral glucose utilization (/-LmoIIlOO g-I min-I ) was calculated from the OD of the regions of interest and the arterial time course of 2-DG using the equation developed by Sokoloff and colleagues (1977) . Physiologic parameters in the mice used for CGU measurement (10 minutes after 2-DG injection) were as follows; Ringer-MAP = 94 ± 9 mm Hg; Pacoz = 34.5 ± 3.4 mm Hg; Pao2 = 144 ± 14 mm Hg; pH = 7.30 ± 0.03; plasma glucose = 8.0 ± 0.8 mmollL; Af3-MAP = 88 ± 8 mm Hg; Pacoz = 36.3 ± 1.9 mm Hg; Paoz = 125 ± 13 mm Hg; pH = 7.33 ± 0.05; plasma glucose = 7.6 ± 1.9 mmollL.
Experimental protocols
Effect of All superfusion on endothelium-dependent and -independent cerebrovascular responses. After �tabili zation of MAP and blood gases (Table 1) , ACh (10 /-LmollL; Sigma), BK (50 /-Lmol/L; Sigma), the calcium ionophore A23187 (3 /-LmollL; Sigma), or S-nitroso-N-acetylpenicillamine (SNAP) (100 to 500 /-LmollL; RBI) was superfused on the ex posed cerebral cortex until the evoked change in CBF reached 135.2 ± 14.6 7.17 ± 0.04* 6 t Mean ± SD.
* P < 0.01 from respect ive control.
t Hypercapnia wa s tested in the same mice in which ACh and SNAP were studied.
a steady state (usually 3 to 5 minutes). The superfusion solution then was switched back to normal Ringer and CBF returned to baseline. In all studies, a small, time-dependent reduction in MAP was observed throughout the experiment. Consequently, MAP tended to be slightly less at the time when the cerebro vascular effects of Af3 superfusion were tested ( Table I) . As in previous studies (Iadecola et aI., 1999; Niwa et aI., 2000a; Zhang et aI., 1997) , the concentrations of ACh, BK, A23187, and SNAP were chosen to produce 50% of maximal responses, as determined by dose-response curves. The increase in CBF produced by systemic hypercapnia was also tested. Hypercap nia (Paco2 = 50 to 60 mm Hg) was induced by introducing CO2 through the circuit of the ventilator. Hypercapnia was monitored by end-tidal CO2 and by measuring Paco2 after the elevation reached a steady state. After testing responses during Ringer superfusion, the superfusion solution was changed to Ringer containing increasing concentrations of Af31-40 (0.01 to 10 /LmoIlL), Af31-42 (0.01 to JO /LmollL), or the control peptide Af340-1 (0.01-10 /LmollL) (Sigma). To minimize ag gregation of the peptide during the experiment, Af3 was freshly solubilized in dimethyl sulfoxide (DMSO) and then diluted in normal Ringer. The final DMSO concentration was <0.2%. Low concentrations of DMSO do not affect resting CBF and do not attenuate the increase in CBF produced by topical applica tion of ACh, BK, A23187, SNAP, and hypercapnia (unpub lished observations; Yang et aI., 1999) . For each Af3 I --40 concentration, responses to ACh, BK, A23187, SNAP, or hypercapnia were tested after 30 to 40 minutes of superfusion. This time interval was selected on the basis of preliminary experiments in which the time course of the cerebrovascular effects of Af3 was investigated.
Effect of All superfusion on eGU in neocortex. Mice were surgically prepared and equipped with the cranial window as described in the CBF experiments. After stabilization of MAP and blood gases, the superfusion solution was switched from normal Ringer to Ringer containing Af31--40 (5 /LmollL; n = 6). Thirty minutes after Af31--40 superfusion, 2-DG was in fused and CGU was determined as described above, Mice in which only normal Ringer was superfused served as controls (n = 6). At the end of the experiment, the position of the window was marked with black ink so that the superfusion site could be identified at the time of brain cutting. The brain was removed and processed for quantitative autoradiography (see above). Cerebral glucose utilization was measured at the superfusion site, in the contralateral homotopic cortical area, and in other neocortical regions listed in Table 2 .
Effect of superoxide scavengers on the cerebrovascular actions of A�. The window was superfused with Ringer and the effect of ACh on CBF was tested. Ringer containing A13 1-40 (5 /-LmoIlL) then was superfused for 30 minutes and the effect of ACh was tested again. The superfusion solution then was changed to Ringer containing Al3l-40 and either SOD (100 to 500 U/mL; n = 6) (Sigma) or the SOD mimetic man ganic(I-II)meso-tetrakis( 4-benzoic acid) porphyrin (MnTBAP; 25 to 100 /-LmollL; n = 6) (Porphyrin Products, Logan, UT, U.S.A.). The effect of ACh on CBF was tested 30 minutes later. Superoxide dismutase is a superoxide scavenger that, because of its molecular weight, is thought to act on extracellular su peroxide (Stamler, 1996) . MnTBAP is a cell-permeant agent that also scavenges superoxide intracellularly (Day et aI., 1995; Faulkner et aI., 1994; Klann, 1998) . In these experiments, ce rebrovascular reactivity to A23 187 and BK was not tested be cause the response to these agents is mediated in part by reac tive oxygen species (Rosenblum, 1987; Rosenblum et aI., 1989; Sobey et aI., 1997) . In some studies, the window was super fused with Ringer containing SOD (500 U/mL; n = 6) or MnTBAP (100 /-LmollL; n = 5) and effects of resting CBF and response to ACh were assessed 30 minutes later.
Effect of superfusion with A�1-40(M3SNle). In some studies (n = 6), the authors investigated the cerebrovascular effects of A131-40 in which the methionine residue in position 35 was substituted with norleucine [AI3 1-40(M35Nle)1, an aminoacid structurally similar to methionine but that lacks the sulfur atom (Varadarajan et aI., 1999) . Such substitution elimi nates the ability of AI3I-40 to generate reactive oxygen species (Varadarajan et aI., 1999) . AI31-40(M35Nle) (purity >95%; lot number: 6640; AnaSpec, San Jose, CA, U.S.A.) was dissolved in DMSO and superfused at a concentration of 5 /-LmollL. Ef fects on resting CBF and on cerebrovascular responses evoked by ACh, BK, A23187, and SNAP were tested after 30 minutes of superfusion.
Data analysis
Data in text and figures are expressed as means ± SD. Two group comparisons were analyzed by the two-tailed t-test for dependent or independent samples, as appropriate. Multiple comparisons were evaluated by the analysis of variance and Tukey's test. Probability values <0.05 were considered statis tically significant.
RESULTS
Effect of All on resting cerebral blood flow and on cerebrovascular reactivity to endothelium-dependent and -independent vasodilators
Cerebral blood flow was stable during superfusion with normal Ringer. However, superfusion with A131-40 (0.01 to 10 f,LmollL) reduced resting CBF in a dose dependent manner (Fig. 1) . Reduction at 5 f,Lmol/L av eraged 29% ± 7% and was not different from the reduc tion observed at 10 f,LmollL (Fig. 1) . Superfusion with A131-40 (5 f,LmollL) attenuated the increase in CBF pro duced by the endothelium-dependent vasodilators ACh (-41 % ± 8%; P < 0.05), BK (-39% ± 9%; P < 0.05), and A23187 (-37% ± 5%; P < 0.05) (Figs. 1 and 2) . In contrast, A[31-40 did not influence the increase in CBF produced by SNAP (100 to 500 fLmolJL) or hypercapnia (Paco2 = 50 to 60 mm Hg), vasodilators that do not act through the endothelium ( Fig. 3 
Effect of All on cerebral glucose utilization
Cerebral blood flow is closely related to CGU, and changes in brain energy metabolism can influence cere brovascular reactivity (Donegan et aI. , 1985) . To deter mine whether the effects of A[31-40 on resting CBF and its reactivity to endothelium-dependent vasodilators were secondary to alterations in CGU, the effect of topi cal cortical superfusion with A[31-40 on CGU was stud ied. As previously reported (Iadecola and Xu, 1994) , CGU in the exposed cortex was slightly greater than that of the contralateral side during Ringer superfusion (Table 2) . However, during A[31-40 superfusion, CGU in the cortex exposed to the peptide was not different from that in the contralateral homotopic cortical area (Table 2) . 
Effect of SOD and MnTBAP on cerebrovascnlar actions of Ap
In mice overexpressing APP and AI3, the alterations in endothelium-dependent responses are counteracted by overexpression of the superoxide-scavenging enzyme SOD (Iadecola et aI., 1999) . Therefore, the authors in vestigated whether the cerebrovascular effects of AI3I-40 also are reversed by the superoxide scavengers SOD or MnTBAP. During Ringer superfusion, AI3I-40 (5 /J-moIlL) attenuated resting CBF and vascular response to ACh (Fig. 4) . Superfusion with SOD (100 to 500 U/mL) or MnTBAP (25 to 100 /J-mol/L) counteracted the attenu ation in a dose-dependent manner (Fig. 4) . MnTBAP was more effective than SOD in restoring resting CBF and reactivity to Ach (Fig. 4) , a finding that can be attributed to the smaller molecular weight and better brain penetra- (Day et aI., 1995; Faulkner et al., 1994; Klann, 1998) . In the absence of AI31-40, SOD (500 DlmL; n = 6) or MnTBAP (100 /J-moIlL; n = 5) did not influence resting CBF (before SOD: 19.4 ± 4.1, after: 19.5 ± 4.1 perfusion units; before MnTBAP: 18.5 ± 5.1; after: 18.5 ± 5.4 perfusion units; P > 0.05) or the increase in CBF produced by ACh (before SOD: 25% ± 3%, after: 25% ± 3%; before MnTBAP: 27% ± 3%, after: 26% ± 2%; P > 0.05).
Effect of APl-40(M3SNle) on cerebral blood flow Substitution of methionine 35 with the structurally similar aminoacid norleucine attenuates the ability of AI3 to generate reactive oxygen species (Varadarajan et aI., 1999) . Therefore, the authors used AI3I-40(M35Nle) to provide additional evidence in support of the hypothesis that the vascular effects of A[31-40 are mediated by re active oxygen species. A[31-40(M3SNle) (S /-LmollL) did not reduce resting CBF (before: 17.4 ± 3.2; after: 17.3 ± 3.6 perfusion units; P> O.OS; n = 6) and did not alter the increase in CBF produced by endothelium-dependent (ACh, BK. A23187) or endothelium-independent vaso dilators (SNAP) (P>O.OS; Fig. S ).
DISCUSSION
The authors sought to detennine whether the alter ations in endothelium-dependent relaxation observed in transgenic mice overexpressing APP result from APP itself or from peptides derived from its processing. Using a cranial window preparation in mice, the authors found that topical superfusion of the neocortex with A[31-40 attenuates the increase in CBF produced by the endothe- ... ACh, BK, and A23187 dilate cerebral blood vessels through different endothelium-delpendent mechanisms (Faraci, 1992; Faraci and Heistad, 1998) . ACh acts by activating endothelial muscarinic receptors and releasing endothelial NO Wei et a!., 1992) . BK activates endothelial BK receptors and pro duces vasodilation by releasing cyc100xygenase products (Mayhan, 1996; Rosenblum, 1987; Sobey et aI., 1997) , whereas A23187 is thought to act by increasing calcium in endothelial cells through receptor-independent mecha nisms (Rosenblum et aI., 1989; Rosenblum and Nelson, 1988) . The fact that A[31-40 attenuates responses to ACh, BK, and A23187 suggests that this peptide pro duces a global failure in endothelium-dependent vasodi lation rather than an alteration of a specific receptor or vasodilator mechanism.
Cerebrovascular effects of A[3 cannot result from changes in MAP and blood gases because these variables were carefully controlled and did not differ among groups. Similarly, the effects of A[31-40 cannot be at tributed to a deterioration of the experimental prepara tion resulting in a progressive and nonspecific impair ment in cerebrovascular reactivity because the CBF re sponse to endothelium-independent vasodilators was not reduced over the same period of time. Furthermore, A[31-42 and A[340-1, which were tested using a timing similar to that of A[31-40, failed to alter resting CBF and to attenuate responses to ACh, BK, or A23187. Reversal by SOD or MnTBAP of the reduction in CBF and vas cular responses A[3 cannot be caused by a nonspecific enhancement of resting CBF and of vasodilator re sponses. The authors have shown here that SOD and MnTBAP do not influence resting CBF and its reactivity to ACh. Similarly, hydrogen peroxide produced by SOD is unlikely to be responsible for the reversal of the en dothelial alteration because this radical is toxic to endo thelial cells (Day et ai., 1997) and would be expected to exacerbate, rather than ameliorate, endothelial dysfunc tion. Furthermore, MnTBAP, an antioxidant that scav enges both superoxide and hydrogen peroxide (Day, et ai., 1997) , yielded results identical to SOD. Therefore, the findings of the current study cannot be attributed to instability of the experimental preparation or to nonspe cific cerebrovascular effect of the pharmacologic agents used.
Cerebral blood flow is closely related to CGU, a vari able reflecting neural activity. Changes in brain energy metabolism can have profound effects on cerebrovascu lar reactivity (Donegan et ai., 1985) . Therefore, the au thors investigated whether A� 1--40 affects CGU. The authors found that Ringer superfusion produces a small but significant increase in CGU in the exposed cortex (ladecola and Xu, 1994) , and that such an increase is abolished by A� superfusion. These data provide evi dence that A� reduces cerebral energy metabolism. However, the small magnitude of the effect suggests that it is unlikely that the A�-induced attenuation in vascular reactivity is because of metabolic depression.
The authors found that A�--42 does not attenuate the increase in CBF produced by endothelium-dependent va sodilators. A� 1-42 has a tendency to aggregate into fibrils, and the state of aggregation can influence its bio logic effects (Pike et aI., 1991 (Pike et aI., , 1995 Weldon et al., \998) . In the authors' experiments, A� 1-42 was studied immediately after solubilization, and the possibility that A� 1-42 in a different aggregated state is more vasoac tive cannot be ruled out. Furthermore, the authors have not examined whether A� 1-42 enhances cerebral vaso constriction, as has been reported for the isolated rat aorta (Crawford et al., 1998) , and whether there is an interaction between the biologic activities of A� 1-40 and A� 1--42. It is surprising, however, that despite the fact that both A�l--40 and A�l--42 produce reactive oxygen species, only A� 1--40 is highly vasoactive. Per haps A� 1--40 is more likely to generate free radicals in vascular cell. Further studies will be required to address this issue.
The observation that treatment with SOD or MnTBAP reversed the A�-induced impairment of endothelium dependent responses indicates that reactive oxygen spe cies are involved in the mechanisms of endothelial cell dysfunction. Consistent with this hypothesis, A� 1-40(M35Nle), a mutated form of A� that does not pro duce free radicals, does not influence endothelium dependent vascular responses. Collectively, these find ings provide strong evidence for an involvement of reactive oxygen species in the cerebrovascular effects of A� 1--40. Although the data suggest that superoxide may be involved, the specific free radical mediating the vas-
cular action of A� remains to be firmly established. In this context, it is of interest that A� did not attenuate the increase in CBF produced by the NO donor SNAP. Su peroxide produced by Af3 could have reacted with NO generated by SNAP to form peroxynitrite (Beckman et ai., 1990) , resulting in an attenuation of SNAPs vasodi latatory potency. One possible explanation for this find ing is that the concentrations of SNAP used were suf ficiently high to mask such superoxide-induced loss of NO.
The site of oxygen radical production and the mecha nisms by which A�-induced reactive oxygen species al ter the function of endothelial cells remain to be eluci dated. Similar alterations in endothelium-dependent vas cular responses are seen in hypertension, diabetes, and atherosclerosis-conditions in which there is increased production of reactive oxygen species at the vascular level (Harrison, 1997; Kontos, 1985; Schmidt et aI., 1999) . Therefore, it is possible that the free radicals re sponsible for endothelial cell dysfunction are also pro duced by vascular cells, for example, by the NAD(P)H oxidase system or by activation of RAGE receptors (Bi anca et ai., 1999; Meda et aI., 1996; Yan et aI., 1996) . As for the mechanism of action, there is evidence that free radicals alter calcium homeostasis in endothelial cells and impair responses, such as release of vasoactive agents, initiated by calcium mobilization (Blanc et ai., 1997; Mattson et aI., 1993 Mattson et aI., , 1997 . However, it remains to be determined whether these alterations observed in vitro occur also in vivo in the experimental preparation.
Experiments in isolated cerebral arteries suggest that Af3I --40 and Af31--42 impair endothelium-dependent re sponses, an effect because of free radical-mediated en dothelial cell destruction (Crawford et aI., 1998; Thomas et aI., 1996) . In the current study, the authors demon strated that the impairment in endothelium-dependent vasodilation produced by A� 1--40 superfusion was com pletely reversed by treatment with superoxide scaven gers. This observation suggested that the cerebrovascular alterations initiated by Af31-40, like those observed in APP mice (Iadecola et aI., 1999) , were caused by a re versible dysfunction of endothelial cells and not by en dothelial cell destruction. Therefore, the mechanisms of A�-induced cerebrovascular impairment in vivo seem to be different from those in isolated arteries.
It is well known that AD is associated with morpho logic alterations of cerebral blood vessels and with an impairment in the regulation of the cerebral circulation (Kalaria, 1999; de la Tone, 1999) . Resting CBF is re duced in the early stages of AD, suggesting that the vascular dysfunction may be an early event that precedes major neuropathologic changes (Friedland, 1990) . Re cent findings suggest that Af3-induced vascular alter ations may have important implications for brain func tion. For example, the increase in somatosensory cortex CBF produced by vibrissal stimulation is attenuated in mice overexpressing APP, an effect with a magnitude proportional to brain A[3 concentration (Niwa et aI., 2000b ) . Furthermore, the increase in CBF induced by functional activation is attenuated in asymptomatic pa tients at high risk for AD, identified on the basis of their ApoE genotype and family history (Smith et aI., 1999) . However, A[3 concentrations in the brains of patients with AD or APP mice are generally less (Hsiao et aI., 1995; Neve and Robakis, 1998) than those described to have cerebrovascular effects in the current study or to be neurotoxic in vitro (Mattson, 1997) . Such a discrepancy could be traced to two factors: first, because A[3 was superfused on the cortical surface, the concentration achieved within the substance of the cerebral cortex is likely to be less than that topically applied; second, un like in APP mice and patients with AD in which the peptide accumulates over months or years, A[3 was ap plied only for a relatively short period of time in the current study. Therefore, it would be of interest to de termine whether lower concentrations of synthetic A[3 applied over longer periods are vasoactive.
In conclusion, the authors demonstrated that exposure of the normal mouse neocortex to A[31---40, but not A[3I-42, produced a profound and selective alteration in the regulation of the cerebral circulation by endothelial cells. Pharmacologic evidence and experiments with mutated A[3 suggest that such effect is mediated by A[3 l ---40-induced formation of reactive oxygen species, which in turn, result in a reversible dysfunction of endothelial cells. The authors concluded that A[31---40 reproduces in full the cerebrovascular dysfunction observed in mice overexpressing mutated APP and that such impairment could be responsible for the alterations in CBF reported in patients with asymptomatic or early AD.
